
Rtw Biotech Opportunities Ltd (RTWG)
LSE
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1.202 | -1.556 | -1.813 | -1.258 | -1.124 |
Return on Equity (%) | -1.21 | -1.58 | -1.949 | -1.439 | -1.226 |
Return on Invested Capital (%) | -5.931 | -15.111 | -779700 | 44.055 | -16.088 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 132.7 | 215.4 | 182.4 | 163.8 | 203.7 |
Earnings Per Share | -0.8 | -2.6 | -3.7 | -2.5 | -2.3 |
Cash Per Share | 6.6 | 2.4 | 3.1 | 3.3 | 1.3 |
Working Capital Per Share | 27.1 | 11.4 | -10.3 | -1 | 29.2 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | -0.8 | -2.6 | -3.7 | -2.5 | -2.3 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 161,55M | 191,52M | 212,39M | 212,39M | 210,64M |
Capitalisation boursière | 447,98M |
Ratio cours/bénéfice | -94,31 |
Ratio prix/ventes | 107,41 |
Ratio prix/liquidités | 165,71 |
Ratio prix/valeur comptable | 1,04 |
Rendement de dividende | - |
Actions en circulation | 386,19M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | 10,48% |
Plus haut sur 52 semaines | 133,00 |
Plus bas sur 52 semaines | 99,40 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales